- Title
- Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation
- Creators
- Ravi Kode - Hahnemann University HospitalKosunarty Fa - University of Pennsylvania, Philadelphia, PA; andShoaib Chowdhury - Hahnemann University HospitalKarthik Ranganna - Hahnemann University HospitalBillie Fyfe - Hahnemann University HospitalSusan Stabler - Hahnemann University HospitalAnna Damask - Hahnemann University HospitalMark R Laftavi - University at Buffalo, State University of New YorkAnil Mysore Kumar - Hahnemann University HospitalOleh Pankewycz - University at Buffalo, State University of New York
- Publication Details
- Clinical transplantation, v 17(4), pp 369-376
- Publisher
- Munksgaard International Publishers
- Edition
- Accepted for publication 1 November 2002
- Number of pages
- 8
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Medicine (Graduate)
- Web of Science ID
- WOS:000184267600010
- Scopus ID
- 2-s2.0-0042121377
- Other Identifier
- 991019168766304721
Journal article
Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation
Clinical transplantation, v 17(4), pp 369-376
Aug 2003
PMID: 12868995
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Metrics
Details
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Surgery
- Transplantation